Meet the best- and worst-performing funds of 2016, per the Financial Times using data from Morningstar. Half of the top 20 losers were health or biotech equities funds, and the biggest losers were a sterling fund and another that made “big bets on a collapse in markets that did not pay off” top the list. An emerging markets fund that lost almost 28% was the third-worst performer. At the head of the class: Funds investing in gold and natural resources, and “five of the top performing funds were Russian equity products.”
More from Enterprise
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
EGX30 gained 2.79% in 3Q, but September gave back most of its July-August run, with mid-caps falling the hardest
Small- and mid-cap indices widened their lead over the benchmark…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…